SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 41 filers reported holding SOLENO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $10,000 | -16.7% | 54,695 | +81.0% | 0.00% | – |
| Q4 2021 | $12,000 | -20.0% | 30,211 | +85.3% | 0.00% | – |
| Q3 2021 | $15,000 | +1400.0% | 16,306 | +1595.0% | 0.00% | – |
| Q2 2021 | $1,000 | -97.9% | 962 | -97.4% | 0.00% | – |
| Q1 2021 | $47,000 | +147.4% | 36,976 | +269.6% | 0.00% | – |
| Q4 2020 | $19,000 | -66.7% | 10,005 | -55.7% | 0.00% | – |
| Q3 2020 | $57,000 | +39.0% | 22,596 | +21.2% | 0.00% | – |
| Q2 2020 | $41,000 | +215.4% | 18,643 | +252.6% | 0.00% | – |
| Q1 2020 | $13,000 | +160.0% | 5,287 | +196.0% | 0.00% | – |
| Q4 2019 | $5,000 | -28.6% | 1,786 | -62.3% | 0.00% | – |
| Q3 2019 | $7,000 | -41.7% | 4,735 | +7.3% | 0.00% | – |
| Q2 2019 | $12,000 | 0.0% | 4,411 | -23.8% | 0.00% | – |
| Q1 2019 | $12,000 | +300.0% | 5,789 | +183.9% | 0.00% | – |
| Q4 2018 | $3,000 | -66.7% | 2,039 | -48.7% | 0.00% | – |
| Q2 2018 | $9,000 | +125.0% | 3,975 | +67.4% | 0.00% | – |
| Q1 2018 | $4,000 | – | 2,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 10,302,602 | $19,884,000 | 6.80% |
| Trellus Management Company, LLC | 662,612 | $1,279,000 | 1.06% |
| ORACLE INVESTMENT MANAGEMENT INC | 3,670,384 | $7,084,000 | 0.89% |
| CVI Holdings, LLC | 1,550,960 | $2,993,000 | 0.56% |
| Nantahala Capital Management | 7,871,356 | $15,192,000 | 0.47% |
| AWM Investment Company, Inc. | 1,550,000 | $2,991,000 | 0.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 322,798 | $623,000 | 0.36% |
| Granite Point Capital Management, L.P. | 1,926,594 | $3,718,000 | 0.19% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,758,200 | $11,113,000 | 0.16% |
| Greylin Investment Management, Inc | 113,195 | $218,000 | 0.05% |